Atnahs Pharma Netherlands B.V.
5 products tracked · names used in filings: Atnahs Pharma Netherlands B.V.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Korjuny catumaxomab | Authorised | 2025-02-10 |
| 🇪🇺 | Sunosi solriamfetol | Authorised | 2020-01-16 |
| 🇪🇺 | Ghryvelin (previously Macimorelin Aeterna Zentaris) macimorelin | Authorised | 2019-01-11 |
| 🇪🇺 | Bonviva ibandronic acid | Authorised | 2004-02-23 |
| 🇪🇺 | Bondronat ibandronic acid | Authorised | 1996-06-25 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.